NervGen Pharma Corp (NGEN) Price Prediction & ForecastNGENNervGen Pharma Corp

Alphio's NGEN stock price prediction model matches the current NervGen Pharma Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.33 (+0.41%). The 1-week path is $1.28 (-2.83%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Nervgen Pharma Corp. is not a good buy right now. The current price is $1.35, which is significantly below the 52-week high of $6.30, indicating a steep decline of 78.40% year-to-date. Additionally, the RSI is at a very low 21.92, suggesting oversold conditions, but this may not be a strong enough signal to counteract the negative financial performance, including a net income loss of CAD 29,217,233 in Q2 2026. The main risk is the ongoing equity dilution from the recent public offering, which could further depress the stock price.

NervGen Pharma Corp (NGEN) last closed at $1.3200001, losing -2.22%. These facts feed the 1-day and 1-week NGEN price prediction above.